InsidersTradesSigma
Track the Polaryx Therapeutics, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). The latest transaction was disclosed on 20 February 2026 (Acquisition). Among the most active insiders: Landis G. Michael. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Polaryx Therapeutics, Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para enfermedades raras. Cotiza en NASDAQ bajo el ticker PLYX.